|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-6-10
|
|
pubmed:abstractText |
EphA2 is a tyrosine kinase receptor in the ephrin family that is implicated in oncogenesis and angiogenesis. The objective of the current investigation was to study the role of EphA2 in endometrial cancer and its relation to steroid hormone receptor expression.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-10544301,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-10561210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-11114742,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-11280802,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-11309274,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-11968011,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-12019162,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-12576426,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-12651595,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-12810680,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-15297418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-16551853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-17077358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-17106249,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-17154180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-18287387,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-2141316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-7536959,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-7590703,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-7705676,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-8152808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19396818-8692240
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2009 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2684-92
|
|
pubmed:dateRevised |
2011-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:19396818-Adult,
pubmed-meshheading:19396818-Aged,
pubmed-meshheading:19396818-Aged, 80 and over,
pubmed-meshheading:19396818-Carcinoma, Endometrioid,
pubmed-meshheading:19396818-Cell Proliferation,
pubmed-meshheading:19396818-Endometrial Neoplasms,
pubmed-meshheading:19396818-Female,
pubmed-meshheading:19396818-Humans,
pubmed-meshheading:19396818-Immunohistochemistry,
pubmed-meshheading:19396818-Middle Aged,
pubmed-meshheading:19396818-Prognosis,
pubmed-meshheading:19396818-Receptor, EphA2,
pubmed-meshheading:19396818-Receptors, Estrogen,
pubmed-meshheading:19396818-Receptors, Progesterone,
pubmed-meshheading:19396818-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
|
|
pubmed:affiliation |
Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1439, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
